Earlier this year we published a post on the new preprint server, medRxiv (pronounced ‘Med Archive’). We touched on the benefits of archiving research via this service, as well as pointing out the potential downsides. But with the COVID-19 pandemic forcing many to work from home and observe social distancing guidelines, preprint services like medRxiv help researchers share their preliminary findings as they seek to better understand this new disease and discover potential treatment options.
With new information on COVID-19 released on a near daily basis, medRxiv is an excellent place to archive research and disseminate it within the medical community.The archival server has a specialized collection dedicated to research pertaining to the study of COVID-19. At the time of the publication of this post, the preprint server holds approximately 4204 articles. With Altmetrics, researchers are able to track the level of engagement their article receives.
Articles located on the preprint server have not undergone the rigorous peer review process.It is imperative that the research located on medrRxiv is not used in a clinical setting nor shared with the media or public. As we learn more about this disease, how best to fight it and how to prevent its spread, members of the medical community must observe best practices and avoid sharing potentially harmful misinformation to the public or media.
The research and news on COVID-19 is constantly evolving. There is still much to learn about this novel coronavirus and medical professionals are working tirelessly to add to the expanding literature on this disease. MedRxiv, the preprint server, has a collection dedicated exclusively to preliminary research on COVID-19. As such, it is an excellent and free resource that puts researchers in contact with each other.
If you would like to learn more about medRxiv or if you’re interested in submitting research to the server, be sure to visit https://www.medrxiv.org/.
